← Leaderboards
Lisa Ann Beck
Johns Hopkins University
$6,300,345
Attributed
$6,300,345
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $522.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,300,345 · 4
By mechanism
U01$2,785,852 · 1
R01$1,629,046 · 1
U19$1,505,745 · 1
R21$379,702 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Nathan K. Archer$3,345,397
- Shawn Gaurav Kwatra$873,384
- Corinne Keet$22,056,351
- Robert A Wood$78,863,893
- Kathleen C Barnes$47,663,132
Others in their field
Top investigators on “Skin”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Donald Ym Leung · University Of Colorado Denver$58,473,424
- Thomas S. Kupper · Dana-Farber Cancer Institute$53,329,207
- Elaine Fuchs · University Of Chicago$41,573,105
- Timothy Burgess · National Institute Of Allergy And Infectious Diseases$35,600,000
- David Leung · National Jewish Health$31,859,607
Research focus
SkinAtopic DermatitisPredispositionResponseSkin DisorderPlayInflammatoryAffectEnrollmentSeverity Of IllnessPathogenesisSystemic TherapyVaccinationChildImmunityProductionBiologyStaphylococcus AureusVirulence FactorsMicrobeSkin BarrierEpithelialSimplexvirusMediating
Grant awards (18)
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$462,039
U01 · FY2025 · AI · contact PI
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$462,039
U01 · FY2024 · AI · contact PI
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$462,039
U01 · FY2023 · AI · contact PI
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$462,039
U01 · FY2022 · AI · contact PI
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$462,098
U01 · FY2021 · AI · contact PI
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD Patients$475,598
U01 · FY2020 · AI · contact PI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis$151,870
U19 · FY2019 · AI · contact PI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis$214,120
U19 · FY2018 · AI · contact PI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis$293,873
U19 · FY2017 · AI · contact PI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis$322,972
U19 · FY2016 · AI · contact PI
Effect of anti-IL4Ra on the Host-Microbe Interface in Atopic Dermatitis$522,910
U19 · FY2015 · AI · contact PI
Effect of the PPAR Agonist Pioglitazone on Epidermal Barrier in Atopic Dermatitis$173,813
R21 · FY2014 · AR · contact PI
Effect of the PPAR Agonist Pioglitazone on Epidermal Barrier in Atopic Dermatitis$205,889
R21 · FY2012 · AR · contact PI
MECHANISMS OF CHEMOKINE-INDUCED INFLAMMATION IN HUMANS$327,000
R01 · FY2005 · AI
MECHANISMS OF CHEMOKINE-INDUCED INFLAMMATION IN HUMANS$327,000
R01 · FY2004 · AI
MECHANISMS OF CHEMOKINE-INDUCED INFLAMMATION IN HUMANS$327,000
R01 · FY2003 · AI
MECHANISMS OF CHEMOKINE-INDUCED INFLAMMATION IN HUMANS$327,000
R01 · FY2002 · AI
MECHANISMS OF CHEMOKINE-INDUCED INFLAMMATION IN HUMANS$321,046
R01 · FY2001 · AI